Drug Approval | August 12, 2021
Human studies begin on AI discovered COVID-19 treatment with up to 97% effectiveness
A treatment to prevent extreme symptoms and cut hospitalisation
A treatment to prevent extreme symptoms and cut hospitalisation
The aim is to create new genomics solutions that could combat cancer and advance market access
The company has tied up with OrbiMed as a financial partner for global reach
This robust performance is a testimony of the company's agility, resilience and strong execution capabilities during these difficult times
The goal for the project is the identification and optimization of anti-viral compounds.
Both companies aim to improve the efficiency and success rate of the current drug discovery process.
The transaction is expected to close in the Q4FY22
Advances deployment of mRNA technology across vaccines and therapeutics development
Reinforcing position as a premier provider of end-to-end research intelligence solutions for Life Sciences
Apollo hospital-Hyderabad, Kainos Hospital-Rohtak and Apex Hospital Jaipur have deployed this solution
Subscribe To Our Newsletter & Stay Updated
